A clinical trial to assess the effectiveness of paracetamol Immediate Release tablets in patients with fever.
Phase 4
Completed
- Conditions
- Health Condition 1: null- Patients having fever at least 38 degrees celsius or 100.4 degrees Fahrenheit
- Registration Number
- CTRI/2011/03/001653
- Lead Sponsor
- Panacea Biotec Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
1.Patients of either sex, 18-65years
2.Patients having fever at least 380C or 100.40F
3.Patients willing to give informed consent
4.Patients able to take oral medications
Exclusion Criteria
1.Subjects requiring hospitalization
2.Subjects with known or suspected hypersensitivity to paracetamol or any the constituents of the formulation.
3.Subjects who have received any other investigational drug within 1 month prior to screening or enrollment.
4.Subjects who have received Paracetamol or any NSAID within 6 hours prior to enrollment.
5.Subjects who are receiving other medications or who have disease conditions that could interfere with the evaluation of drug efficacy or drug safety.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method